YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II

Phase 1

Recruiting

Conditions: Cannabis

Interventions: Drug: Inhaled THC
Drug: Placebo

First Posted Date: 2021-01-11

Last Posted Date: 2024-07-18

Lead Sponsor: Yale University

Target Recruit Count: 100

Registration Number: NCT04704271

Locations: 🇺🇸
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven, Connecticut, United States

Parental Guidance for Failure to Launch.

Not Applicable

Completed

Conditions: Anxiety Disorders
Failure to Launch
Hikikomori

Interventions: Behavioral: SPACE parental-guidance

First Posted Date: 2021-01-11

Last Posted Date: 2024-01-22

Lead Sponsor: Yale University

Target Recruit Count: 40

Registration Number: NCT04704583

Locations: 🇺🇸
Yale University Child Study Center, New Haven, Connecticut, United States

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Phase 2

Recruiting

Conditions: Advanced Non-small Cell Lung Cancer

Interventions: Drug: NC318 400 mg
Drug: NC318 800 mg
Drug: Pembrolizumab

First Posted Date: 2021-01-07

Last Posted Date: 2024-05-24

Lead Sponsor: Yale University

Target Recruit Count: 159

Registration Number: NCT04699123

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

PRagmatic Trial Of Messaging to Providers About Treatment of Heart Failure in the Inpatient Setting

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Best practice alert for the notification of patient HFrEF and recommended evidence-based medical therapies (NO drugs are being administered in this trial)

First Posted Date: 2020-12-29

Last Posted Date: 2024-01-26

Lead Sponsor: Yale University

Target Recruit Count: 1012

Registration Number: NCT04686604

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)

Phase 1

Completed

Conditions: Cystic Fibrosis

Interventions: Other: Placebo
Drug: Standard Dose YPT-01

First Posted Date: 2020-12-24

Last Posted Date: 2023-11-18

Lead Sponsor: Yale University

Target Recruit Count: 8

Registration Number: NCT04684641

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake

Not Applicable

Completed

Conditions: Influenza
Whooping Cough

Interventions: Behavioral: AFIX-OB Quality Improvement Package

First Posted Date: 2020-12-21

Last Posted Date: 2023-09-21

Lead Sponsor: Yale University

Target Recruit Count: 202

Registration Number: NCT04678271

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Weight Regain Treatment Post-Bariatric Surgery

Phase 2

Completed

Conditions: Obesity, Overweight

Interventions: Behavioral: Behavioral Weight Loss (BWL)

First Posted Date: 2020-12-10

Last Posted Date: 2023-11-13

Lead Sponsor: Yale University

Target Recruit Count: 26

Registration Number: NCT04662801

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care

Recruiting

Conditions: Congenital Uterine Anomaly

First Posted Date: 2020-12-09

Last Posted Date: 2024-04-11

Lead Sponsor: Yale University

Target Recruit Count: 300

Registration Number: NCT04661072

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

AB154 Combined with AB122 for Recurrent Glioblastoma

Early Phase 1

Recruiting

Conditions: Glioblastoma

Interventions: Drug: Zimberelimab
Drug: Domvanalimab
Drug: Placebo

First Posted Date: 2020-12-07

Last Posted Date: 2024-12-17

Lead Sponsor: Yale University

Target Recruit Count: 46

Registration Number: NCT04656535

Locations: 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸
Yale University, New Haven, Connecticut, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Behavior Therapy for Irritability in Autism

Not Applicable

Recruiting

Conditions: Anger
Irritability
Autism Spectrum Disorder
Disruptive Behavior
Asperger Syndrome
Pervasive Developmental Disorder
Aggression

Interventions: Behavioral: Behavioral Therapy for Irritability in Autism
Behavioral: Psychoeducation and Supportive Therapy (PST)

First Posted Date: 2020-12-04

Last Posted Date: 2024-04-02

Lead Sponsor: Yale University

Target Recruit Count: 126

Registration Number: NCT04654260

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy